Genomic Sanger sequencing (left) showed two peaks representing mutant [G] and wild-type [A] nucleotides, indicating PDGFRA heterozygosity in tumor cells or contamination with the genome from healthy cells. The gene discussed is PDGFRA; the disease is neoplasm.